Clinical trial
A Randomized Controlled Multicentre Trial, Examining the Effect of Natrox® Oxygen Wound Therapy on the Healing Rate of Chronic Diabetic Foot Ulcers
NCT03905863 is registered in ClinicalTrials.gov with Inotec AMD Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled Multicentre Trial, Examining the Effect of Natrox® Oxygen Wound Therapy on the Healing Rate of Chronic Diabetic Foot Ulcers
- Lead sponsor
- Inotec AMD Limited
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 4, 2019
- Completion date
- October 18, 2020
- Enrollment
- 145 (actual)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic foot ulcer, surgical wound